-
Heart failure with preserved ejection fraction: from mechanisms to therapiesLam CSP, Voors AA, de Boer RA et al. -
Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHFBA Davison, S Senger, IE Sama et al.
-
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID TrialW Zareba, JP Daubert, CA Beck et al.
-
Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart FailureWang Y, Yang H, Marwick TH et al.
-
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trialMorrow DA, Velazquez EJ, DeVore AD et al.
-
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFMartinez FA, Serenelli M, Nicolau JC et al.
-
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative reviewBurlacu A, Simion P, Nistor I et al.
-
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)DP Leong, JJV McMurray, PG Joseph et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
